Tumor hypoxia: Definitions and current clinical, biologic, and molecular aspects

Journal of the National Cancer Institute

Volumn 93, Issue 4, 2001, Pages 266-276

  Höckel, Michael ^a   Vaupel, Peter ^b  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMINOLEVULINIC ACID; CARBOPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; HEMATOPORPHYRIN DERIVATIVE; HYPOXIA INDUCIBLE FACTOR 1; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; OXYGEN; PHOTOSENSITIZING AGENT; PROTEOME;

ANIMAL CELL; CANCER GROWTH; CANCER THERAPY; CELL FUNCTION; DRUG RESISTANCE; ELECTRON TRANSPORT; HOMEOSTASIS; HUMAN; HUMAN CELL; HYPOXIA; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; OXYGEN TENSION; PATHOPHYSIOLOGY; PHOTODYNAMIC THERAPY; PHYSIOLOGY; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SOLID TUMOR;

EID: 0035925098     PISSN: 00278874     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnci/93.4.266     Document Type: Review

References (162)

1. The concentration of oxygen dissolved in tissues at the time of irradiation as a factor in radiotherapy
2. Cellular basis of radiotherapy
3. Hypoxia and its clinical significance
4. The unique physiology of solid tumors: Opportunities (and problems) for cancer therapy
5. Hypoxia, clonal selection, and the role of HIF-1 in tumor progression
6. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
7. Tumor hypoxia and gene expression - Implications for malignant progression and therapy
8. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix
9. Tumor oxygenation predicts the likelihood of distant metastases in human soft tissue sarcoma
10. Tumour hypoxia and vascular density as predictors of metastasis in squamous cell carcinoma of the uterine cervix
11. Tumor hypoxia in pelvic recurrences of cervical cancer
12. High lactate levels predict likelihood of metastases, tumor recurrence, and restricted patient survival in human cervical cancers
13. Exposure to hypoxia, glucose starvation and acidosis: Effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion
14. Hypoxia-mediated stimulation of carcinoma cell invasiveness via upregulation of urokinase receptor expression
15. Hypoxic cervical cancers with low apoptotic index are highly aggressive
16. Hypoxia induces DNA overreplication and enhances metastatic potential of murine tumor cells
17. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck
18. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells
19. Hypoxia-mediated selection of cells with diminished apoptotic potential in solid tumours
20. Selection of human cervical epithelial cells that possess reduced apoptotic potential to low-oxygen conditions
21. Heat shock proteins increase resistance to apoptosis
22. Tumor radiosensitivity and apoptosis
23. Microsatellite instability, apoptosis, and loss of p53 function in drug-resistant tumor cells
24. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
25. Apoptosis and cancer chemotherapy
26. Transient hypoxia enhances the frequency of dihydrofolate reductase gene amplification in Chinese hamster ovary cells
27. Oxidative phosphorylation and photophosphorylation
28. Proposal for using a standardized terminology on oxygen transport to tissue
29. Glossary on respiration and gas exchange
30. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: A review
31. Blood flow, oxygen consumption, and tissue oxygenation of human breast cancer xenografts in nude rats
32. Blood flow, metabolism, cellular microenvironment, and growth rate of human tumor xenografts
33. i
34. Acute changes of systemic parameters in tumour-bearing rats, and of tumour glucose, lactate, and ATP levels upon local hyperthermia and/or hyperglycaemia
35. Physiological properties of malignant tumours
36. Energy status and radiobiological hypoxia at specified oxygen concentrations
37. Measurement of low levels of oxygen and their effect on respiration in cell suspensions maintained in an open system
38. Methodical studies on the polarographic measurement of respiration and "critical oxygen pressure" in mitochondria and isolated cells with membrane-covered platinum electrodes
39. The respiration of ascites tumour cells at low oxygen concentrations
40. Oxygen diffusion and mitochondrial respiration in neuroblastoma cells
41. The oxygen dependence of mitochondrial oxidative phosphorylation measured by a new optical method for measuring oxygen concentration
42. Basic principles of tissue oxygen determination from mitochondrial signals
43. Impact of anemia on the oxygenation status of tumors: A theoretical study
44. Oxygenation and bioenergetic status of murine fibrosarcomas
45. Pathophysiological approaches to identifying tumor hypoxia in patients
46. Measurement of tumor hypoxia by invasive and non-invasive procedures: A review of recent clinical studies
47. Oxygen in human tumors: Correlations between methods of measurement and response to therapy
48. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays
49. 2-histography
50. 2 tension measurements
51. 2 tension measurements
52. Measurement of tumor oxygenation: A comparison between polarographic needle electrodes and a time-resolved luminescence-based optical sensor
53. The OxyLite: A fibre-optic oxygen sensor
54. 2 in vivo, including human subjects, by electron paramagnetic resonance
55. Oxymetry deep in tissues with low-frequency electron paramagnetic resonance
56. Heterogeneous oxygenation of rectal carcinomas in humans: A critical parameter for preoperative irradiation?
57. Intracapillary oxyhemoglobin saturation of malignant tumors in humans
58. 2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: Relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells
59. Cryospectrophotometric determination of tumor intravascular oxyhemoglobin saturations: Dependence on vascular geometry and tumor growth
60. Quantitation of time-and frequency-resolved optical spectra for the determination of tissue oxygenation
61. Carbogen-induced changes in rat mammary tumour oxygenation reported by near infrared spectroscopy
62. Localization of tumors and evaluation of their state of oxygenation by phosphorescence imaging
63. Tumour response to hypercapnia and hyperoxia monitored by FLOOD magnetic resonance imaging
64. Monitoring cancer by magnetic resonance
65. Magnetic resonance spectroscopy and imaging methods for measuring tumour and tissue oxygenation
66. 19F PBSR EPI of hexafluorobenzene
67. 19F-MR relaxometry
68. 19F NMR spectroscopy of hexafluorobenzene
69. In vivo measurements of vascular oxygen tension in tumors using MRI of a fluorinated blood substitute
70. Non-invasive determination of tumor oxygen tension and local variation with growth
71. Imaging of hypoxia in human tumors with [F-18]fluoromisonidazole
72. Evaluation of oxygenation status during fractionated radiotherapy in human nonsmall cell lung cancers using [F-18]fluoromisonidazole positron emission tomography
73. 18F]fluoromisonidazole: A pretherapy study of 37 patients
74. Hypoxia in human gliomas: Demonstration by PET with fluorine-18-fluoromisonidazole
75. Misonidazole labeling as a marker of cellular hypoxia
76. Imaging tumor hypoxia and tumor perfusion
77. 123I-iodoazomycin arabinoside: Preliminary report of a clinical study
78. 3H-misonidazole to solid human tumors as a measure of tumor hypoxia
79. Distribution of the hypoxia marker CCI-103F in canine tumors
80. Immunohistochemical detection of a hypoxia marker in spontaneous canine tumours
81. Calibration of misonidazole labeling by simultaneous measurement of oxygen tension and labeling density in multicellular spheroids
82. Measuring Tumor Hypoxia
83. Longevity of pimonidazole adducts in spontaneous canine tumors as an estimate of hypoxic cell lifetime
84. Proliferation and hypoxia in human squamous cell carcinoma of the cervix: First report of combined immunohistochemical assays
85. Detection of hypoxic cells by monoclonal antibody recognizing 2-nitroimidazole adducts
86. Direct relationship between radiobiological hypoxia in tumors and monoclonal antibody detection of EF5 cellular adducts
87. 2-Nitroimidazole (EF5) binding predicts radiation resistance in individual 9L s.c. tumors
88. Pimonidazole: A novel hypoxia marker for complementary study of tumor hypoxia and cell proliferation in cervical carcinoma
89. Oxygen dependence of cellular uptake of EF5 [2-(2-nitro-1H-imidazol-1-y1)-N-(2,2,3,3,3-pentafluoropropyl)acetamide]: Analysis of drug adducts by fluorescent antibodies vs bound radioactivity
90. Measurement of hypoxia in vivo using a 2-nitroimidazole (NITP)
91. Hypoxic stress proteins: Survival of the fittest
92. Keynote address: The influence of microenvironmental factors on the activity of radiation and drugs
93. Tumor hypoxia: Its impact on cancer therapy
94. Early wound healing exhibits cytokine surge without evidence of hypoxia
95. Cellular physiology and molecular events in hypoxia-induced apoptosis
96. Regulation of cell proliferation under extreme and moderate hypoxia: The role of pyrimidine (deoxy) nucleotides
97. The effect of hypoxia on the generation time of mammalian cells
98. Inhibition of cell-cycle progression by acute treatment with various degrees of hypoxia: Modifications induced by low concentrations of misonidazole present during hypoxia
99. Apaf-1 and caspase-9 in p53-dependent apoptosis and tumor inhibition
100. Oncogenic alterations of metabolism
101. Prevention of hypoxia-induced cell death by Bcl-2 and Bcl-xL
102. Dormancy of micrometastases: Balanced proliferation and apoptosis in the presence of angiogenesis suppression
103. Local recurrences following mastectomy: Support for the concept of tumor dormancy
104. The inhibition of tumor growth by tumor mass
105. 2 tension
106. Association of resistance-related protein expression with poor vascularization and low levels of oxygen in human rectal cancer
107. Hypoxia-induced resistance to doxorubicin and methotrexate in human melanoma cell lines in vitro
108. Regulation of c-jun expression during hypoxic and low-glucose stress
109. Hypoxia induces accumulation of p53 protein, but activation of a G1-phase checkpoint by low-oxygen conditions is independent of p53 status
110. Enhanced epidermal growth factor receptor synthesis in human squamous carcinoma cells exposed to low levels of oxygen
111. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
112. Drug resistance in Chinese hamster ovary cells during recovery from severe hypoxia
113. Hypoxia-induced up-regulation of angiogenin in human malignant melanoma
114. Hypoxia facilitates tumour cell detachment by reducing expression of surface adhesion molecules and adhesion to extracellular matrices without loss of cell viability
115. 2 tension
116. The beta domain of pVHL is necessary for HIF-alpha regulation
117. Regulation of hypoxia-inducible mRNAs by the von Hippel-Lindau tumor suppressor protein requires binding to complexes containing elongins B/C and Cu12
118. The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis
119. A quantitative analysis of the reduction in oxygen levels required to induce up-regulation of vascular endothelial growth factor (VEGF) mRNA in cervical cancer cell lines
120. Hypoxia causes the activation of nuclear factor κB through the phosphorylation of IκBα on tyrosine residues
121. Tumour hypoxia: The picture has changed in the 1990s
122. Therapeutic significance of microenvironmental factors
123. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor
124. Oxygen dependence of hematoporphyrin derivative-induced photo-inactivation of Chinese hamster cells
125. Oxygen dependency of tumor cell killing in vitro by light-activated Photofrin II
126. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors
127. Genetic instability induced by the tumor microenvironment
128. Anoxia-inducible endonuclease activity as a potential basis of the genomic instability of cancer cells
129. Genomic instability and tumor progression: Mechanistic considerations
130. An anoxia inducible endonuclease and enhanced DNA breakage as contributors to genomic instability in cancer
131. Benign-to-malignant B16 melanoma progression induced in two stages in vitro by exposure to hypoxia
132. Classification of anti-neoplastic treatments by their differential toxicity toward putative oxygenated and hypoxic tumor subpopulations in vivo in the FSaII murine fibrosarcoma
133. Classification of antineoplastic agents by their selective toxicities toward oxygenated and hypoxic tumor cells
134. The effect of hypoxia on the growth and radiation response of mammalian cells in culture
135. The influence of microenvironmental factors during cancer therapy
136. The relevance of tumour pH to the treatment of malignant disease
137. Hypoxia-induced drug resistance: Comparison to P-glycoprotein-associated drug resistance
138. Tumor hypoxia, reoxygenation and oxygenation strategies: Possible role in photodynamic therapy
139. Oxygen dependence of the photosensitizing effect of hematoporphyrin derivative in NHIK 3025 cells
140. Microcirculation modifications by localized microwave hyperthermia and hematoporphyrin phototherapy
141. Microvasculature and perfusion in normal tissues and tumors
142. Metabolic status and reaction to heat of normal and tumor tissue
143. The influence of variable oxygen concentration on the response of cells to heat or X irradiation
144. Oxygen distribution in squamous cell carcinoma metastases and its relationship to outcome of radiation therapy
145. 2 predicts survival in advanced cancer of the uterine cervix
146. Hypoxia and radiation response in human tumors
147. The relationship between tumor oxygenation and cell proliferation in human soft tissue sarcomas
148. 2-measurements as predictive assay in the treatment of carcinoma of the uterine cervix
149. Human tumor oxygenation: The Duke University Medical Center experience
150. Pretreatment oxygenation predicts radiation response in advanced squamous cell carcinoma of the head and neck
151. Oxygenation predicts radiation response and survival in patients with cervix cancer
152. Treatment outcome in advanced squamous cell carcinoma of the uterine cervix: Relationships to pretreatment tumor oxygenation and vascularization
153. 31P MR spectroscopy in human soft tissue sarcomas
154. Hypoxia in human soft tissue sarcomas associated with poor survival
155. Microenvironment-induced cancer metastasis
156. Hypoxia modulated gene expression: Angiogenesis, metastasis and therapeutic exploitation